Effect of treatment of hepatic histopathology in children and adolescents with autoimmune hepatitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 46, Issue 1, 2008, Pages 65-70

  Ferreira, Alexandre Rodrigues ^a,b   Roquete, Mariza Leitão Valadares ^a   Toppa, Nivaldo H ^a   De Castro, Lúcia Porto Fonseca ^a   Fagundes, Eleonora Druve Tavares ^a   Penna, Francisco José ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FM/UFMG ^*  (Brazil)

Author keywords

Autoimmune hepatitis; Cirrhosis; Histopathology; Necroinflammatory activity; Treatment

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER NECROSIS; MALE; PRIORITY JOURNAL; REMISSION;

BIOPSY, NEEDLE; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER; LIVER CIRRHOSIS; MALE;

EID: 37549065963     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000304456.84552.13     Document Type: Article

References (33)

1. Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541-7.
2. Maggiore G, Bernard O, Homberg JC, et al. Liver disease associated with anti-liver-kidney microsome antibody in children. J Pediatr 1986;108:399-404.
3. Maggiore G, Veber F, Bernard O, et al. Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr 1993;17:376-81.
4. Ferreira AR. Hepatite auto-imune em crianças e adolescentes: estudo clínico, diagnóstico, e resposta terapêutica [master's thesis] Belo Horizonte, Brazil: Faculdade de Medicina, Universidade Federal de Minas Gerais; 1999.
5. Ferreira AR, Roquete MLV, Penna FJ, et al. Hepatite auto-imune em crianças e adolescentes: estudo clínico, diagnóstico, e resposta terapêutica. J Pediatr (Rio J) 2002;78:309-14.
6. McSween RNM, Anthony PP, Scheuer PJ. Pathology of the Liver. 3rd ed. Edinburgh, UK: Churchill Livingston; 1987.
7. Rojkind M, Dunn M. Hepatic fibrosis. Gastroenterology 1979;76:849-63.
8. Wanless IR. Use of corticosteroid therapy in autoimmune hepatitis resulting in the resolution of cirrhosis. J Clin Gastroenterol 2001;32:371-2.
9. Schvarcz R, Glaumann H, Weiland O. Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitis. J Hepatol 1993;18:15-23.
10. Dufour JF, Dilellis R, Kaplan MM. Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med 1997;127:981-5.
11. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.
12. Alvarez F, Berg PA, Bianchei FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
13. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
14. Maggiore G, Bernard O, Hadchouel M, et al. Treatment of autoimmune chronic active hepatitis in childhood. J Pediatr 1984;104:839-44.
15. Czaja AJ, Beaver SJ, Shiels MT. Sustained remission following corticosteroid therapy of severe HBsAg-negative chronic active hepatitis. Gastroenterology 1987;92:215-9.
16. Czaja AJ, Carpenter HA. Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis. Liver Int 2003;23:116-23.
17. Scheuer PJ, Maggi G. Hepatic fibrosis and collapse: histological distinction by orcein staining. Histopathology 1980;4:487-90.
18. Ferrel LD, Theise ND, Scheuer PJ. Acute and chronic viral hepatitis. In: McSween FNM, Burt AD, Portmann BC, et al (eds). Pathology of the liver. 4th ed. Edinburgh, UK: Churchill Livingstone; 2002. pp. 313-362.
19. Falkner S, Samuelson G, Sjolin S. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease. Pediatrics 1970;45:260-8.
20. Powell LW, Kerr JF. Reversion of cirrhosis in idiopathic hemochromatosis following long-term intensive venesection therapy. Australas Ann Med 1970;2:54-7.
21. Kaplan MM, Delellis RA, Wolfe HJ. Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment. Ann Intern Med 1997;26:682-8.
22. Cotler SJ, Jakate S, Jensen DM. Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy. J Clin Gastroenterol 2001;32:428-30.
23. Czaja AJ, Carpenter HA. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol 2004;40:646-52.
24. Sobesky R, Mathurin P, Charlotte F, et al. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. Gastroenterology 1999;116:378-86.
25. Poynard T, McHutchison J, Davis GL, et al. Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. Hepatology 2000;32:1131-7.
26. Poynard T, McHutchison J, Manns M. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002;122:1303-13.
27. Kweon YO, Goodman ZD, Dienstag JL, et al. Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis. Br J Hepatol 2001;35:749-55.
28. Lau DT, Kleiner DE, Park Y, et al. Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy. Gastroenterology 1999;117:1229-33.
29. Hammel P, Couvelard A, O'Toole D, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 2001;344:418-23.
30. Soloway RD, Baggenstoss A, Schoenfield L, et al. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis 1975;20:1087-90.
31. Gronbaek K, Christensen PB, Hamilton-Dutoit S, et al. Interobserver variation in interpretation of serial liver biopsies from patients with chronic hepatitis C. J Virol Hepatol 2002;9:443-9.
32. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
33. Westin J, Lagging LM, Wejstal R, et al. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver 1999;19:183-7.